SCHEMBL7316883

SCHEMBL7316883

Cc1ccsc1C1(O)c2ccccc2-c2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 1/20 0.41
▸ OPRD1 P41143 1/20 0.41
▸ OPRK1 P41145 1/20 0.41
▸ OPRL1 P41146 1/20 0.41
▸ PDK2 Q15119 8/20 0.37
▸ ESR1 P03372 1/20 0.37
▸ ESR2 Q92731 1/20 0.37
▸ TDP1 Q9NUW8 3/20 0.36
▸ THRB P10828 1/20 0.36
▸ HTT P42858 2/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ BRD4 O60885 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ ADORA2A P29274 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ RECQL P46063 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7316576 0.78 CYP2D6 (0.41) PDK2TDP1THRBALDH1A1MAPT
SCHEMBL7313758 0.77 THRB (0.43) PDK2TDP1THRBALDH1A1RAB9A
SCHEMBL7316356 0.76 PDK2 (0.40) PDK2TDP1THRBALDH1A1MAPT
SCHEMBL7316321 0.74 THRB (0.39) OPRK1PDK2TDP1THRBMEN1
SCHEMBL7313945 0.72 PDK2 (0.46) OPRM1OPRD1OPRK1OPRL1PDK2
SCHEMBL7316444 0.72 PDK2 (0.47) PDK2MEN1MAPTKMT2APOLB
SCHEMBL7319520 0.72 PDK2 (0.44) PDK2
SCHEMBL27619850 0.72 PDK2 (0.47) PDK2TDP1THRBMEN1MAPT
SCHEMBL7314142 0.71 PDK2 (0.40) PDK2TDP1THRBALDH1A1KMT2A
SCHEMBL11133761 0.71 PDK2 (0.36) OPRM1OPRD1OPRK1OPRL1PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6162824-A NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS ALLELIX NEUROSCIENCE INC. 2000-12-19 — — US disclosed
WO-1999041227-A1 TRICYCLIC COMPOUNDS AS GLYCINE TRANSPORT INHIBITORS ALLELIX NEUROSCIENCE, INC. (US) 1999-08-19 — — WO disclosed
Send feedback